These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21422210)

  • 1. In vitro activities of anidulafungin and other antifungal agents against biofilms formed by clinical isolates of different Candida and Aspergillus species.
    Fiori B; Posteraro B; Torelli R; Tumbarello M; Perlin DS; Fadda G; Sanguinetti M
    Antimicrob Agents Chemother; 2011 Jun; 55(6):3031-5. PubMed ID: 21422210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
    Maiolo EM; Furustrand Tafin U; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2014 May; 58(5):2709-17. PubMed ID: 24566186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of anidulafungin, caspofungin, fluconazole and amphotericin B against biofilms and planktonic forms of Candida species isolated from blood culture in patients with hematological malignancies.
    Malchikova A; Klyasova G
    J Mycol Med; 2021 Sep; 31(3):101162. PubMed ID: 34147758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates.
    Simitsopoulou M; Peshkova P; Tasina E; Katragkou A; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2562-70. PubMed ID: 23529739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii.
    Simitsopoulou M; Kyrpitzi D; Velegraki A; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4953-6. PubMed ID: 24890585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
    Martín Mazuelos E; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():7-13. PubMed ID: 19572429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ; Gómez-Perosanz M; Escribano P; Zaragoza O; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
    J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the echinocandin caspofungin with amphotericin B or voriconazole against Aspergillus biofilms in vitro.
    Liu W; Li L; Sun Y; Chen W; Wan Z; Li R; Liu W
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6414-6. PubMed ID: 23027186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.
    Ruan SY; Chu CC; Hsueh PR
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2919-22. PubMed ID: 18458136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp.
    Serrano Mdel C; Valverde-Conde A; Chávez M M; Bernal S; Claro RM; Pemán J; Ramirez M; Martín-Mazuelos E
    Diagn Microbiol Infect Dis; 2003 Feb; 45(2):131-5. PubMed ID: 12614985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.
    Katragkou A; Chatzimoschou A; Simitsopoulou M; Dalakiouridou M; Diza-Mataftsi E; Tsantali C; Roilides E
    Antimicrob Agents Chemother; 2008 Jan; 52(1):357-60. PubMed ID: 17938192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
    Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
    J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.